English | Español
Ruth de Jauregui | Jun 4, 2017

American Heart Association praises CMS for approving therapy for peripheral artery disease
Robert Hadley | Jun 4, 2017

Merck’s targeted tumor drug approved for colorectal and other cancers
Robert Hadley | Jun 3, 2017

FDA OKs Novartis' Zykadia for metastatic lung cancer affecting the brain
Robert Hadley | Jun 2, 2017

FDA approves higher once-a-day dose of Merck’s Isentress HIV drug 
Ruth de Jauregui | Jun 2, 2017

American Heart Association says study finds link between preeclampsia and stroke
Tabitha Fleming | Jun 2, 2017

European Commission approves dinutuximab beta for treating high-risk neuroblastoma
Erianne Leatherman | Jun 2, 2017

American Academy of Physicians Assistants, CancerLinQ to partner on cancer care research
Ruth de Jauregui | Jun 2, 2017

Phase III trials of Ofev show positive results for idiopathic pulmonary fibrosis patients

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’